MNKD MannKind Corporation
Healthcare$3.53+4.44%ClosedMarket Cap: $1.09B
As of 2026-05-26
Valuation
P/E (TTM)
135.05
PEG
—
P/B
-17.60
P/S
2.89
EV/EBITDA
50.11
DCF Value
$-41.62
FCF Yield
1.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.0%
Operating Margin
3.7%
Net Margin
-6.6%
ROE
45.6%
ROA
-3.2%
ROIC
1.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $90.2M | 75.8% | $-3.0M | $-16.6M | $— | — |
| Q4 null | $112.0M | 78.5% | $-7.7M | $-15.9M | $— | — |
| FY null | $349.0M | 82.5% | $38.8M | $5.9M | $— | — |
| Q3 null | $82.1M | 75.4% | $18.8M | $8.0M | $— | — |
| Q2 null | $76.5M | 73.1% | $5.3M | $668.0K | $— | — |
| Q1 null | $78.4M | 77.6% | $22.3M | $13.2M | $— | — |
| Q4 null | $76.8M | 74.5% | $26.5M | $7.4M | $— | — |
| FY null | $285.5M | 73.2% | $72.6M | $27.6M | $— | — |
| Q3 null | $70.1M | 74.3% | $12.8M | $11.6M | $— | — |
| Q2 null | $72.4M | 71.8% | $16.6M | $-2.0M | $— | — |
| Q1 null | $66.3M | 71.9% | $16.7M | $10.6M | $— | — |
| Q4 2023 | $58.5M | 69.1% | $7.9M | $1.4M | $0.00 | — |